postCOVID

Study reveals how vaccination reduces post-COVID risks across distinct subtypes, offering insights into personalized care and recovery strategies. Study: Refinement of post-COVID condition core symptoms, subtypes,…
Read More...

Petrovax announced today the positive results from "Long-CoV-III-21," a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer in adult patients with pulmonary…
Read More...